89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 88 filers reported holding 89BIO INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $419,844 | -23.3% | 27,192 | -5.9% | 0.01% | -26.3% |
| Q2 2023 | $547,503 | +24.4% | 28,892 | 0.0% | 0.02% | +18.8% |
| Q1 2023 | $440,025 | +19.6% | 28,892 | 0.0% | 0.02% | +14.3% |
| Q4 2022 | $367,795 | +120.2% | 28,892 | 0.0% | 0.01% | +100.0% |
| Q3 2022 | $167,000 | +74.0% | 28,892 | -2.7% | 0.01% | +75.0% |
| Q2 2022 | $96,000 | – | 29,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 400,000 | $1,288,000 | 6.98% |
| TCG Crossover Management, LLC | 1,133,196 | $3,649,000 | 1.55% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $4,508,000 | 1.08% |
| DAFNA Capital Management LLC | 766,774 | $2,469,000 | 0.67% |
| RA Capital Management | 7,782,669 | $25,060,000 | 0.67% |
| BVF INC/IL | 3,898,000 | $12,552,000 | 0.61% |
| Boxer Capital, LLC | 1,400,000 | $4,508,000 | 0.29% |
| Orbimed Advisors | 3,658,869 | $11,782,000 | 0.21% |
| Newtyn Management, LLC | 310,000 | $998,000 | 0.19% |
| Orchard Capital Management, LLC | 168,493 | $592,000 | 0.18% |